Early Access — free while we kick the tires
EdgarHawk

Brockett Charles C.

Director

Director
4 filings analyzed · 1 company · Latest 2025-11-24

Companies

Company Buys Sells Direction
MainStreet Bancshares, Inc. MNSB 9 0 Net buying

Activity

November 2025
medium
Buy
742 shares
$14,113
Significance 6/10

Director Brockett buys 742 shares of MNSB in 4 transactions for $14,112.90; holdings surge 498.0% from 149 to 891 shares.

Director Charles C. Brockett executed 4 separate purchases totaling 742 shares for $14,112.90 on 2025-11-24, raising his position from 149 to 891 shares (+498.0%). The blended average purchase price of $19.02 sits 1.2% above the current price of $18.80, within the 52-week range of $15.27–$22.93. At the same ticker, Brockett's prior trade on 2025-05-29 showed a 90-day return of +19.6%, indicating at least one instance of favorable post-purchase price movement; however, his most recent prior buy on 2024-11-25 delivered -13.7% over 90 days, and the win rate on same-ticker buys stands at 1 of 5 (20.0%). The company generated $33.6M in quarterly revenue with $4.5M net income and posted 7.9% annual revenue growth, but was unprofitable on a full-year basis, presenting a mixed fundamental backdrop.

May 2025
low
Buy
120 shares
$2,294
Significance 3/10

Director Brockett bought 120 shares of MNSB at $19.12; stock now $18.95, down 7.4% from 52-week high.

Director Charles C. Brockett purchased 120 shares of MainStreet Bancshares at $19.12 on May 29, 2025, a modest accumulation that increased his holdings from 92,808 to 92,928 shares. At current price of $18.95, the transaction is underwater by approximately 1%, and the stock trades 7.4% below its 52-week high of $20.46, though it has gained 15.0% over the past 90 days. Brockett's prior purchases at MNSB show mixed timing outcomes: only 1 of 5 prior trades achieved positive 90-day returns, with the most recent November 2024 purchases returning between -7.7% and -2.1% at the 90-day mark, while his cross-ticker track record shows an even weaker 36.36% 90-day win rate. The company's fundamentals reveal a small-cap regional bank ($146.0M market cap) that posted negative full-year net income despite recent quarterly profitability ($2.5M net income on $33.9M quarterly revenue) and 7.9% annual revenue growth, creating operational uncertainty that may explain the modest transaction size and middling prior execution outcomes at this ticker.

November 2024
medium
Buy
300 shares
$5,643
Significance 4/10

Director Brockett bought 300 shares at $18.81, now holding 92,808 shares; stock down -28.5% from 52-week high.

Charles C. Brockett, a director at MainStreet Bancshares, purchased 300 shares at $18.81 on November 25, 2024, following three prior buys four days earlier on November 21. The current price of $18.42 is -28.5% from the 52-week high of $25.75, positioning the purchase within a depressed price environment. At the same ticker, his two prior measurable buys from April 2024 both delivered positive 90-day returns (+10.4%), and his cross-ticker track record shows a 57.14% win rate over 90 days with an average return of +4.7%. The pattern of repeated near-term accumulation and prior success at this ticker warrants attention, though near-term price momentum remains modest (+2.4% over 30 days).

medium
Buy
370 shares
$6,749
Significance 4/10

Director Brockett Charles C. bought 370 shares of MNSB at $18.24 avg; stock up 9.2% in 90 days

Charles C. Brockett, a Director, executed 3 separate open-market purchases totaling 370 shares for $6,748.90 at a blended average price of $18.24 on 2024-11-21, increasing his holdings to 26.3K shares. The current price of $18.35 sits 28.7% below the 52-week high of $25.75, and the stock has gained 9.2% over the past 90 days. His prior 5 trades at MNSB show mixed results: 2 of 5 purchases were followed by positive 90-day returns (notably +10.4% in April 2024), while 3 were followed by flat or negative 90-day outcomes. His cross-ticker buy track record shows 7 prior purchases with a 57.14% 90-day win rate and an average 90-day return of +4.7%. The company's revenue declined 11.2% year-over-year, though the current valuation (P/E 12.32, market cap $139.5M) remains modest and the near-term price trend has been positive.

Related insiders

Create a free account

Build watchlists, get email alerts on the tickers you follow, and read the full AI analysis on every insider filing.

Sign up — free during early access